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Summary
Objective: To investigate the mRNA expression profiles of three mammalian hyaluronan synthases (HAS1, HAS2 and HAS3) in chondrocytes
from normal (undiseased) animal cartilage and osteoarthritic human cartilage maintained in experimental culture systems and exposed to
catabolic or anabolic stimuli provided by cytokines, growth factors and retinoic acid.
Design: Chondrocytes isolated from normal bovine, porcine or from osteoarthritic human cartilage were cultured as monolayers or
embedded in agarose. Cultures were maintained for 3–5 days in the presence or absence of catabolic stimuli (IL-1, TNF- or retinoic acid)
or anabolic stimuli (TGF- or IGF-1) followed by extraction of RNA and analysis of HAS mRNA expression by RT-PCR.
Results: Whereas mRNA for HAS1 was not detected in any sample, the mRNAs for HAS2 and HAS3 were expressed in human, bovine and
porcine chondrocytes. HAS2 mRNA was present in chondrocytes from all cartilages and under all culture conditions, whereas HAS3 did not
show such constitutive expression. In agarose cultures of bovine and porcine chondrocytes HAS2 mRNA was present in control, IL-1 and
retinoic acid treated cultures, whereas HAS3 mRNA was only detected in IL-1 stimulated cultures. Mature bovine chondrocytes cultured in
monolayers expressed mRNAs for both HAS2 and HAS3 in the presence of IL-1, TNF-, TGF- and IGF-1, however immature bovine
chondrocytes in monolayer cultures displayed virtually no HAS3 mRNA expression in the presence of these cytokines and growth factors.
HAS2 and HAS3 mRNAs were also expressed by bovine chondrocytes isolated from either the superficial or deep zone of articular cartilage,
and by human chondrocytes cultured either in the absence or presence of IL-1 and retinoic acid.
Conclusions: Our data indicate that HAS2 and HAS3 (but not HAS1) mRNAs are expressed in several mammalian cartilages. Chondrocyte
HAS2 mRNA appears to be constitutively expressed while chondrocyte HAS3 mRNA expression can be differentially regulated in an
age-dependent fashion, and may be affected by local and/or systemic catabolic or anabolic stimuli provided by cytokines or growth factors.
© 2000 OsteoArthritis Research Society International
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Hyaluronan (HA) is a non-sulfated glycosaminoglycan
composed of the repeating disaccharide unit [D-glucuronic
acid (1--3) N-acetyl-D-glucosamine (1--4)] which exists
as a high molecular weight polymer (Mr>106 Da) in the
extracellular matrix of many tissues in the body. HA has
been shown to play an important role in a number of
cellular functions including mitosis,1 cell migration,2 joint
cavitation in development3,4 and interaction with cell sur-
face receptors.5 Unlike the other component molecules of
extracellular matrix which are synthesized intracellularly,
HA is produced and extruded at the cell surface,6–8 thereby
enabling unconstrained assembly of very long polymers.
Recently, a family of enzymes responsible for the synthesis
of HA has been identified. The first member of this protein
family (designated HAS for HA Synthase) to be identified
was spHAS from Streptococcus pyogenes.9 More recently,
a homologous Xenopus laevis protein, DG42 (or xlHAS),120has been shown to synthesize HA in vitro,10 and three
distinct mammalian HAS gene products have been
described: human and murine HAS1,11,12 human and
murine HAS213–15 and murine HAS3.16 All members of the
HAS gene family are proposed to have a common domain
structure possessing multiple membrane-spanning regions
and a conserved central (intracellular) domain which is
likely to contain the catalytic site within the enzymes.17
Interestingly, the three HAS isoforms have been shown to
exhibit different activities in vitro, with each enzyme gener-
ating HA chains of varying length.18,19 Furthermore, in both
humans and mice, the three HAS enzymes are found on
different chromosomes,20 thereby implicating additional
mechanisms for the control of HAS activity (e.g. at the level
of mRNA transcription).
In cartilage, HA is synthesised by the resident
chondrocytes21–23 and incorporated into the extracellular
matrix where it binds to aggrecan and link protein, thereby
providing a critical role in enabling and promoting the
maintenance of multimolecular hydrophilic aggregates
which facilitate the load bearing properties of the tissue.
Age-related variations in both the size and tissue content of
HA have been described for human articular cartilage,24
and such changes could clearly have profound effects on
cartilage function. At present, however, there is little infor-
mation regarding the mechanisms whereby HA polymer
size and/or concentration could be modulated in cartilage.Received 24 May 1999; accepted 21 September 1999.
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ties) of the different HAS isoforms could certainly play a
role in this process, and cytokine or growth factor stimu-
lation, which affects the synthesis of many cartilage mol-
ecules, is likely to influence chondrocyte HA synthesis as
well. Indeed, elevated levels of HA have been detected in
porcine articular cartilage explant cultures treated with
IL-1,25 while the tissue content of HA is reduced in similar
bovine explant cultures exposed to this cytokine.26 In this
study, we have utilized model chondrocyte culture systems
derived from three different mammalian species (human,
bovine and porcine) and from animals of different ages to
examine the relative mRNA expression levels of HAS1,
HAS2 and HAS3, both under control conditions and in
response to physiological effector molecules (cytokines,
growth factors and retinoids) which we hypothesized might
play a role in regulating HAS gene expression. Our results
demonstrate that articular cartilage chondrocytes express
HAS2 mRNA constitutively, while HAS3 mRNA expression
can vary with age and in response to cytokine/growth factor
exposure, thereby indicating that the relative activities of
these two enzymes could contribute to functional variations
in HA composition during cartilage metabolism.Materials and methods
CELL ISOLATION AND CULTURE
Culture media and supplements were from Gibco/Life
Technologies (Paisley, U.K.) unless otherwise indicated.
Bovine and porcine cartilage was obtained from the meta-
carpophalangeal joints of immature (<10 days old) or
mature (>18 months old) cattle and from immature (3–6
months old) pigs. Human articular cartilage was from the
femoral condyles of a 78-year-old patient obtained follow-
ing arthroplasty for advanced osteoarthritis of the knee.
Chondrocytes from full-depth cartilage slices were isolated
by sequential pronase and collagenase digestion and
maintained in monolayer or agarose cultures as
described.27 Cultures were maintained for 3–5 days in
DMEM containing gentamicin (50 g/ml) and the ascorbate
analogue phosphatin-C (25 mg/ml) in the presence or
absence of 10 ng/ml IL-1, 1 M all-trans retinoic acid,
40 ng/ml TNF-, 2 ng/ml TGF-1 or 10 ng/ml IGF-1 (all
from Sigma, Dorset, U.K.).
For some experiments, bovine chondrocytes were iso-
lated as described from the separate superficial and deep
zones of metacarpophalangeal cartilage from immature or
mature animals.28,29 During this procedure, the mid-zone
cartilage was discarded to avoid cross contamination of
the superficial and deep zone tissue. Zone-specific cells
were maintained in monolayer or agarose culture as
described.30PROCEDURES FOR RNA EXTRACTION AND RT-PCR
Total RNA was extracted from chondrocyte cultures
using Tri-Reagent (Sigma, Dorset, U.K.) at a ratio of 1 ml
extractant/10 cm2 culture area. Each 1 ml portion of Tri-
Reagent extract was mixed with 0.2 ml of chloroform and
incubated for 15 min at room temperature. After centrifuga-
tion for 20 min at 16,000×g, the upper aqueous phase was
mixed with an equal volume of isopropanol and incubated
for a further 15 min at room temperature. Precipitated
RNA was concentrated by centrifugation for 20 min at
∼16,000×g and the RNA pellet washed with 1 ml of 75%ethanol. After drying, each RNA pellet was dissolved in
sterile water. RNA was also isolated directly from freshly
excised cartilage as described.27 Briefly, tissue slices
(10–50 mg wet weight) which had been blotted on filter
paper were snap-frozen in liquid nitrogen and pulverized
for 1.5 min at 2000 rpm in a liquid nitrogen-cooled Micro-
Dismembrator vessel (B. Braun Biotech International
GmbH, Germany). A 1-ml aliquot of Tri-Reagent was then
added directly to the powdered cartilage and warmed to
room temperature. Total RNA from each Tri-Reagent
extract was then isolated as described above for chondro-
cyte cultures. All RNA samples were subsequently
treated with RNase-free DNase I (Pharmacia, Herts, U.K.)
and re-purified by phenol extraction and isopropanol
precipitation.
RT-PCR was performed on the RNA samples using
oligonucleotide primers specific for HAS1, HAS2, HAS3
or glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
(Table I). Total RNA was reverse-transcribed using either
the antisense primers for HAS/GAPDH or random hex-
amers. PCR amplification was then performed on the
resulting cDNA using the appropriate primers. PCR prod-
ucts were separated on 1.5% agarose gels and visualized
by staining the gel with 0.5 g/ml ethidium bromide. Rep-
resentative examples of at least three separate RT-PCR
analyses for each experiment are shown in Figs 1–4.
All PCR products were sequenced by dye terminator
cycle sequencing (ABI Prism Model 377) to validate the
specificity of the primers for the appropriate template.ResultsHAS mRNA EXPRESSION IN SITU AND IN AGAROSE CULTURES
In order to determine which of the HA synthases were
being expressed in situ in articular cartilage, we first exam-
ined RNA samples extracted directly from freshly excised
bovine and porcine tissue. Of the three mammalian HAS
enzymes identified to date, only HAS2 and HAS3 mRNAs
were expressed in native bovine or porcine cartilage (Fig.
1A). There was no evidence for expression of HAS1 in
bovine or porcine chondrocytes under any of the culture
conditions. The effects of IL-1 and retinoic acid treatment
on HAS2 and HAS3 expression in mature bovine and
immature porcine chondrocytes maintained in agarose cul-
tures were next examined. Both bovine and porcine
chondrocytes grown in agarose cultures expressed HAS2
mRNA, and this expression was maintained in the pres-
ence of retinoic acid or IL-1 (Fig. 1B). However, under the
same culture conditions (control, IL-1, and retinoic acidTable I
Oligonucleotide primers used for RT-PCR. Primer sequences
correspond to human and rodent cDNAs deposited in GenBank
Target
template
PCR primers Product
size (bp)
HAS1 5′-TGACCATCTCCGCCTACCAG 500
5′-CCCACCAACAGCCCCTACCC
HAS2 5′-TCCTCCTGGGTGGTGTGATTT 297
5′-TGTCTCCTTTGGTGGCATTAT
HAS3 5′-ACAGAGACCCCCACTAAG 221
5′-AGCAGGAAGAGGAGAATG
GAPDH 5′-TGGYATCGTGGAAGGRCTCAT 370
5′-RTGGGWGTYGCTGTTGAAGTC
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cultures. Similarly, for immature porcine chondrocytes cul-
tured in agarose, a low level of HAS3 mRNA expression
was observed only in IL-1 stimulated cultures (Fig. 1B).HAS mRNA EXPRESSION IN BOVINE CHONDROCYTES FROM
IMMATURE AND MATURE ANIMALS
Bovine chondrocytes isolated from both immature and
mature animals were cultured in monolayers in the pres-
ence or absence of the different cytokines (IL-1 or TNF-),
growth factors (TGF- or IGF-1) or retinoic acid for 3 days
and investigated for the expression of HAS1, HAS2 or
HAS3 mRNA (Fig. 2). As was observed for the other bovine
samples tested (see Fig. 1), HAS1 mRNA was not detect-
able in extracts from mature or immature bovine chondro-
cytes. In contrast, HAS2 mRNA was readily detected in all
samples (Fig. 2A), and appeared to be constitutively
expressed in both mature and immature cartilage. HAS3
mRNA was present in the mature animal samples regard-less of the influence of the growth factors or cytokines
tested (Fig. 2B). For immature bovine chondrocytes, how-
ever, HAS3 mRNA transcripts were detected in untreated
cultures but were essentially absent in extracts from
cytokine or growth factor treated cultures (Fig. 2B).
We next examined HAS mRNA expression in chondro-
cytes isolated from different morphological zones (super-
ficial and deep zones) of bovine articular cartilage.
Chondrocytes were grown in monolayers in the presence of
10% FBS and total RNA was extracted after 5 days in
culture. Verification that the superficial chondrocyte pheno-
type was predominantly expressed in cultures of cells
isolated from the superficial zone (as opposed to the deep
zone) was obtained by performing Western blot analysis
on culture media samples with the superficial zone
proteoglycan-specific antibody 3-A-4.28–30 Superficial zone
proteoglycan was detected exclusively in the media from
the superficial zone-derived chondrocytes from either
immature or mature cartilage (results not shown). Both
HAS2 and HAS3 mRNAs were present in extracts from theFig. 1. RT-PCR analysis of mature bovine and immature porcine chondrocyte HAS2 and HAS3 mRNA expression in (A) freshly excised
tissue and (B) cells grown in agarose cultures and maintained in the presence or absence of 1 M retinoic acid (RA) or 10 ng/ml IL-1.
Expression of GAPDH mRNA was assessed to control both for the quality and quantitiy of the RNA analyzed. Primer sequences are given
in Table 1 and the migration of DNA size markers is shown on the right of each panel.
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immature and mature animals (Fig. 3).HAS mRNA EXPRESSION IN HUMAN CHONDROCYTES FROM
OSTEOARTHRITIC CARTILAGE
As observed for mature bovine chondrocytes in mono-
layer culture (see Fig. 2), adult (osteoarthritic) human
chondrocytes cultured in monolayers also expressed HAS2
and HAS3 mRNAs (Fig. 4) with no evidence for HAS1
mRNA expression. The human chondrocytes also
expressed both HAS2 and HAS3 when cultured in the
presence of two different catabolic stimuli, IL-1 or retinoic
acid. Under the RT-PCR assay conditions utilized in this
study, there was no discernible difference in HAS2 or HAS3
mRNA levels in response to cytokine or retinoic acid
treatment.Discussion
In the present study we have documented the mRNA
expression profiles of HA synthase isoforms in chondro-
cytes from osteoarthritic human and from undiseased
mature or immature animal articular cartilage, both within
the native tissue and in cells maintained under two differentculture conditions (i.e. in monolayers or embedded in
agarose). The results demonstrate that while HAS1 mRNA
was not expressed in any of the samples analyzed, HAS2
mRNA appeared to be expressed constitutively, whereas
expression of HAS3 was influenced by culture conditions,
animal age and cytokine or growth factor stimulation.
Extracts of freshly excised bovine and porcine cartilage
contained mRNAs for both HAS2 and HAS3 (Fig. 1A).
Expression of HAS2 mRNA was maintained when bovine
or porcine chondrocytes were cultured in agarose gels,
however HAS3 mRNA expression was detected only in IL-1
treated agarose cultures (Fig. 1B), suggesting that cell
phenotype and matrix microenvironment can influence
HAS3 expression. In this regard, we have recently reported
similar observations on the levels of expression of mRNA
transcripts for other human, bovine and porcine chondro-
cyte genes which can vary dependent on cell environment
in situ and in vitro.27 In the present study, bovine chondro-
cytes maintained in monolayer cultures expressed HAS2
mRNA constitutively in both mature and immature cells
cultured with a panel of cytokines and growth factors (Fig.
2A). In these same cultures, however, HAS3 mRNA expres-
sion by immature chondrocytes was only detected in the
absence of cytokine/growth factor stimulation (Fig. 2B).
When superficial or deep zone bovine chondrocytes were
grown in monolayer cultures, expression of mRNAs forFig. 2. RT-PCR analysis of (A) bovine chondrocyte HAS2 and (B) bovine chondrocyte HAS3 mRNA expression in cells from mature and
immature cartilage grown in monolayer cultures and maintained in the presence or absence of 10 ng/ml IL-1, 2 ng/ml TGF, 10 ng/ml IGF-1
or 40 ng/ml TNF-. Primer sequences are given in Table 1 and the migration of DNA size markers is indicated.
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study Ng et al. reported an ∼2-fold higher level of HA
synthesis in superficial compared to deep layer bovine
articular cartilage explants grown in culture.23 However,
since >90% of the newly synthesized HA in cartilage
explant cultures appears to be endocytosed and degraded
by the chondrocytes,31 such measurements may not be
wholly indicative of HAS activity.
Finally, monolayer cultures of human chondrocytes
derived from osteoarthritic cartilage also expressed HAS2
and HAS3 mRNAs, both in the absence and presence of
IL-1 or retinoic acid (Fig. 4).
Insights into some of the mechanisms whereby HAS
enzyme expression and activity can be affected have been
obtained from previous studies investigating the regulation
of HA biosynthesis by effector molecules in a variety of cell
types. For example, Ohkawa et al. recently demonstrated
that increased HA synthesis mediated by the p50/p65
NFB complex in TNF-- and TGF-1-stimulated myo-
fibroblasts correlates with increased levels of HAS1
mRNA.32 In contrast, Mohamadzadeh et al. reported that
HAS1 mRNA levels were unaffected during IL-1 and TNF-
induced synthesis of HA by endothelial cells.33 In earlierstudies, Sampson et al. showed that treatment of human
lung fibroblasts with either TNF-, IFN- or IL-1 stimulated
the production of high molecular weight HA.34 Interestingly,
however, exposure of these same cells to both TNF- and
IFN- in combination increased the activity of HA syn-
thase(s), but resulted in the generation of low molecular
weight HA, thereby implicating the involvement of
HA-degrading enzymes (hyaluronidases). In a recent
study,35 we identified three hyaluronidase isoforms
(HYAL1, HYAL2 and HYAL3) which are expressed in articu-
lar cartilage and detected hyaluronidase activity in
chondrocyte culture media and cell membrane extracts
when assays were performed at pH 4.5 or pH 3.7 (with no
activity observed at pH 7.5). Furthermore, the amount of
hyaluronidase activity detected did not change significantly
in chondrocyte cultures treated with IL-1 or TNF-. These
data concur with those of Sampson et al., who found that
HA degradation did not correlate with lung fibroblast
hyaluronidase(s) active at pH 3.7, but did correlate with
binding of HA to the cells.34 Expression of the HA receptor
CD44 by these lung fibroblasts was increased in response
to IL-1 or TNF- stimulation, as has been observed for IL-1
or TNF- treated chondrocytes,36,37 thereby implicatingFig. 3. RT-PCR analysis of bovine chondrocyte HAS2 and HAS3 mRNA expression in cells from immature and mature cartilage superficial
(S) and deep (D) zones grown in monolayer cultures. Expression of GAPDH mRNA was assessed to control both for the quality and quantitiy
of the RNA analyzed. Primer sequences are given in Table 1 and the migration of DNA size markers is indicated.Fig. 4. RT-PCR analysis of human chondrocyte HAS2 and HAS3 mRNA expression in cells grown in monolayer and maintained in the
presence or absence of 0.1% DMSO (vehicle for retinoic acid addition), 10 ng/ml IL-1 or 1 M retinoic acid (RA). Expression of GAPDH
mRNA was assessed to control both for the quality and quantitiy of the RNA analyzed. Primer sequences are given in Table 1 and the
migration of DNA size markers is shown on the right.
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somal) degradation of HA as a major and important
determinant involved in HA metabolism.
Additional studies have demonstrated increases in HA
synthesis mediated via protein kinase C-dependent
mechanism(s) in human fibroblasts stimulated with TGF-1
or PDGF-BB.40 Similarly, HA synthesis was stimulated in
human synovial lining cells exposed to TGF-141 and in a
human rheumatoid synovial cell line exposed to IL-1.42 In
the latter study, however, TGF-1 inhibited the synthesis of
HA. In this regard, TGF-1 has been shown to upregulate
both HAS1 and HAS2 mRNA levels in mouse skin fibro-
blasts, but upregulates only HAS1 mRNA expression in
keratinocytes,43 suggesting that different cell types (i.e.,
with varied phenotypes) may respond differently to stimuli
associated with the regulation of HAS expression/activity.
Our current results indicate that such cell/phenotype-
specific modulation of HAS expression occurs in cartilage
since HAS3 mRNA expression was detected in IL-1 treated
(but not retinoic acid treated or untreated) bovine and
porcine chondrocytes cultured in agarose (Fig. 1B). In
monolayer cultures, however, mature bovine chondrocytes
expressed HAS3 mRNA under all experimental conditions,
whereas immature bovine chondrocytes expressed HAS3
mRNA only in control cultures, but not in cultures stimulated
with IL-1, TNF-, TGF- or IGF-1 (Fig. 2B).
In summary, we have shown that chondrocytes from
three different mammalian species can express two of the
three known HAS enzymes (i.e. HAS2 and HAS3, but not
HAS1). In support of these observations, Nishida et al.
recently reported that HAS1 mRNA was undetectable in
monolayer cultures of human articular chondrocytes.44 In
addition, the deduced copy number for HAS2 mRNA in their
cultures was ∼40-fold higher than that of HAS3. These
studies, combined with our findings reported here showing
constitutive expression of chondrocyte HAS2 mRNA,
strongly indicate a major role for HAS2 in maintaining HA
homeostasis in cartilage. HAS3 expression, on the other
hand, is more sensitive to changes in the cellular environ-
ment, being altered in response to factors such as culture
conditions and cytokine exposure. It is important to note
that results from studies examining gene transcription
should be augmented by additional investigations designed
to analyze potential translational and post-translational
effects on protein synthesis and enzymatic activity. For
example, it will be of interest to determine whether post-
translational modifications affect the activity of the HAS
isoforms. Unlike prokaryotic (bacterial) HAS, which would
be synthesized in an unglycosyated form, mammalian
HAS enzymes may be substituted at oligosaccharide-
attachment consensus sequences (i.e. NXS/T for N-linked
substitution) which occur within their sequence. Addition-
ally, correct disulfide bond formation through conserved
cysteine residues (particularly those in the catalytic regions
of the proteins) may be critical for enzyme activity. Future
studies aimed at elucidating such aspects of HAS regu-
lation will provide important additional new insights into
hyaluronan metabolism in articular cartilage and other
connective tissues.Acknowledgments
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